Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3784477018 | Selinexor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3784478011 | Selinexor (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selinexor | Is a | Triazole (substance) | false | Inferred relationship | Some | ||
| Selinexor | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Selinexor | Is a | Substance with triazole structure (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Selinexor-containing product | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Product containing only selinexor (medicinal product) | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Product containing selinexor in oral dose form (medicinal product form) | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Selinexor only product in oral dose form | Has active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
| Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Selinexor | Inferred relationship | Some | 1 |
| Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Selinexor | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR